Reports for GLN-OLMESARTAN HCTZ

Brand name
GLN-OLMESARTAN HCTZ

Company Name

GLENMARK PHARMACEUTICALS CANADA INC.

Drug Identification Number

02475715

Ingredients & Strength

Anatomical Therapeutical Chemical (ATC) Code

  • C09DA
  • C09DA

Anatomical Therapeutical Chemical (ATC) Descriptor

  • ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
  • ANGIOTENSIN II ANTAGONISTS, COMBINATIONS

Status

MARKETED
Shortage reports
Brand name Packaging size Status Date Created Date Updated Reports
GLN-OLMESARTAN HCTZ 90 tablets Resolved 2024-11-07 2025-05-06 242244
GLN-OLMESARTAN HCTZ 30 tablets Actual shortage 2026-03-03 2026-03-17 279517
GLN-OLMESARTAN HCTZ 90 tablets Resolved 2026-03-03 2026-03-03 279524

Showing 1 to 3 of 3

Discontinuation reports
Brand name Packaging size Status Date Created Date Updated Reports

Showing 1 to 0 of 0